Phase I study in healthy participants to evaluate safety, tolerability, and pharmacokinetics of inhaled nezulcitinib, a potential treatment for COVID‐19.
| Autor: | Pfeifer, Nathan D.1 (AUTHOR) npfeifer@theravance.com, Lo, Arthur1 (AUTHOR), Bourdet, David L.1 (AUTHOR), Colley, Kenneth1 (AUTHOR), Singh, Dave2 (AUTHOR) |
|---|---|
| Zdroj: | CTS: Clinical & Translational Science. Nov2021, Vol. 14 Issue 6, p2556-2565. 10p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|